Background illustration for clinical trials search

Paid Clinical Trials Allentown

Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

MASA Valve Early Feasibility Study

for
Tetrology of Fallot, Pulmonary Stenosis, Truncus Arteriosus,
Location: Philadelphia PA, Boston MA, Cincinnati OH, Peoria IL,
Sponsor: PECA Labs

Sex: All

Age: 0 - 22

Code: NCT05452720

Recruiting

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

for
Metastatic Prostate Carcinoma,
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: Male

Age: 18+

Code: NCT05487846

Recruiting

Applying pGz in Mitochondrial Disease

for
Mitochondrial Myopathies, Mitochondrial Diseases
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 10 - 60

Code: NCT05569122

Phase 1, Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Philadelphia PA, Kingston PA, Cherry Hill NJ, Edison NJ,
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase 2, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Philadelphia PA, New Brunswick NJ, Morristown NJ,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

for
Deep Venous Thrombosis
Location: Philadelphia PA, Hershey PA, New York NY, Valhalla NY,
Sponsor: Yale University

Sex: All

Age: 0 - 17

Code: NCT04924322

Phase 2, Phase 3, Recruiting

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study

for
ADPKD
Location: Philadelphia PA, Washington D.C. DC, Rochester MN
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT04338048

Recruiting

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Location: Philadelphia PA, Washington D.C. DC, Boston MA, Toronto,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 0 - 21

Code: NCT04655404

Early Phase 1, Recruiting

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

for
Refractory Acute Myeloid Leukemia,
Location: Philadelphia PA, New York NY, Cincinnati OH, Atlanta GA,
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 1 - 30

Code: NCT06177067

Phase 1, Recruiting

Optimal Ventilation for Cardiac Arrest

for
Cardiac Arrest (CA)
Location: Philadelphia PA, Wilmington DE, New Hyde Park NY,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT07114510

Recruiting

Down Syndrome Obstructive Sleep Apnea

for
Down Syndrome, Obstructive Sleep Apnea
Location: Philadelphia PA, Norfolk VA, Cleveland OH, Ann Arbor MI,
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 5 - 18

Code: NCT06043440

Phase 2, Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: New Brunswick NJ, New York NY, Baltimore MD,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07011719

Phase 3, Recruiting

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Philadelphia PA, Baltimore MD, Bethesda MD,
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 1 - 8

Code: NCT06188741

Phase 2, Recruiting

Lurbinectedin in FET-Fused Tumors

for
Ewing Sarcoma, Desmoplastic Small Round Cell Tumor,
Location: Philadelphia PA, New York NY, Boston MA, Ann Arbor MI,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 10+

Code: NCT05918640

Phase 1, Phase 2, Recruiting

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

for
Mitochondrial Disorders, Mitochondrial Genetic Disorders,
Location: Philadelphia PA, New York NY, Washington D.C. DC,
Sponsor: Columbia University

Sex: All

Age: 0+

Code: NCT01694940

Recruiting

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

for
Cytomegalovirus Infections, Primary Immune Deficiency Disorder
Location: Philadelphia PA, Valhalla NY, Baltimore MD, Columbus OH,
Sponsor: New York Medical College

Sex: All

Age: 0 - 70+

Code: NCT03266640

Phase 2, Recruiting

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

for
Stargardt Disease, Cone Rod Dystrophy,
Location: Philadelphia PA, Boston MA, Ann Arbor MI, Cincinnati OH,
Sponsor: Ascidian Therapeutics, Inc

Sex: All

Age: 12+

Code: NCT06467344

Phase 1, Phase 2, Recruiting

Gene Therapy for HER-Positive Cancer (SENTRY-HER2)

for
HER2 Expressing Solid Tumors
Location: Philadelphia PA, Hackensack NJ, New York NY,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT07192432

Phase 1, Phase 2, Recruiting

Imaging Assessments of ARPKD Kidney Disease Progression

for
Autosomal Recessive Polycystic Kidney Disease
Location: Philadelphia PA, Cleveland OH
Sponsor: The Cleveland Clinic

Sex: All

Age: 6+

Code: NCT07201025

Recruiting

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

for
Malignant Neoplasm
Location: Philadelphia PA, New Brunswick NJ, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07630974

Phase 1, Phase 2, Recruiting